KöhlerG., and MilsteinC. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity.Nature, London256, 495–497.
3.
SchadeR., StaakC., HendriksenC., ErhardM., HuglH., KochG., LarssonA., PollmannW., van RegenmortelM., RijkeE., SpielmannH., SteinbuschH., and StraughanD. (1996). The production of avian (egg yolk) antibodies: IgY. The report and recommendations of ECVAM workshop 21.ATLA24, 925–934.
4.
Anon. (1989). Code of Practice for the Production of Monoclonal Antibodies, 6 pp. Rijswyk, The Netherlands: Veterinary Public Health Inspectorate, Department of Animal Experimentation.
5.
KuhlmannI., KurthW., and RuhdelI. (1989). Monoclonal antibodies: in vivo and in vitro production on a laboratory scale, with consideration of the legal aspects of animal protection.ATLA17, 73–82.
6.
PorterW.P., QuanderR.V., and RenerJ.C. (1990). Laboured breathing in ascites-producing mice.Lab Animals18, 21–22.
7.
van der KampM., & de LeeuwW.A. (1996). Short review of in vitro production methods for monoclonal antibodies.NCA Newsletter3, 10–12.
8.
HewishD. (1996). Ascites and alternatives.ANZCCART News9, 8–10.
9.
KovarJ., and FranekF. (1984). Serum-free medium for hybridoma and parental myeloma cultivation: a novel composition of growth-supporting substances.Immunology Letters7, 339–345.
10.
ChangT.H., SteplewskiZ., and KoprowskiH. (1980). Production of monoclonal antibodies in serum-free medium.Journal of Immunological Methods39, 369–375.
11.
FikeR.M., JaymeD.W., and WeissS.A. (1991). Monoclonal antibody enhancement in protein-free and serum-supplemented hybridoma culture.American Biotechnology Laboratory9, 40–42.
12.
MizrahiA. (1977). Primatone® RL in mammalian cell culture media.Biotechnology and Bio-engineering13, 1557–1561.
13.
VelezD., ReuvenyS., MillerL., and MacmillanJ.D. (1986). Kinetics of monoclonal antibody production in low serum growth medium.Journal of Immunological Methods86, 45–52.
14.
SchacterE. (1989). Serum-free medium for bulk culture of hybridoma cells and the preparation of monoclonal antibodies.Trends in Biotechnology7, 248–253.
15.
HewlettG. (1991). Strategies for optimising serum-free media.Cytotechnology5, 3–14.
16.
StollT., MohlethalerK., von StockarU., and MarisonI. (1996). Systematic improvement of a chemically-defined protein-free medium for hybridoma growth and monoclonal antibody production.Journal of Biotechnology45, 111–123.
17.
StollT., ChappazA., von StockarU., and MarisonI. (1997). Effects of culture conditions on the production and quality of monoclonal IgA.Enzyme and Microbial Technology, in press.
18.
ChuaF., OhS., YapM., and TeaW. (1994). Enhanced IgG production in cRDF media with and without serum.Journal of Immunological Methods167, 109–119.
19.
ParekhR.B., DwekR.A., SuttonB.J., FernandesD.L., LeungA., StanworthD., and RademacherT.W. (1985). Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.Nature, London316, 452–456.
20.
LeatherbarrowR.J., RademacherT.W., and DwekR.A. (1985). Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor.Molecular Immunology22, 407–415.
21.
LeibigerH., HansenA., SchoenherrG., SeifertM., WustnerD., StiglerR., and MarxU. (1995). Glycosylation analysis of a polyreactive human monoclonal IgG antibody derived from a human-mouse heterohybridoma.Molecular Immunology32, 595–602.
22.
FischerR.W., and FerberP.C. (1992). Monoklonale Antikoerper: In vitro-Produktionsmethoden im Vergleich.Alternativen zu Tierexperimenten16, 15–24.
23.
StollT., PerregauxC., von StockarU., and MarisonI.W. (1995). Production of immunoglobulin A in different reactor configurations.Cytotechnology17, 53–63.
24.
JacksonL.R., TrudelL.J., FoxJ.G., and LipmanN.S. (1996). Evaluation of hollow fibre bioreactors as an alternative to murine ascites production for small scale monoclonal antibody production.Journal of Immunological Methods189, 217–231.
25.
HendriksenC., RozingJ., van der KampM., & de LeeuwW. (1996). The production of monoclonal antibodies: are animals still needed?ATLA24, 109–110.
26.
WinterG., GriffithsA.D., HawkinsR.E., and HoogenboomH.R. (1994). Making antibodies by phage display technology.Annual Review of Immunology12, 433–455.
27.
BurtonD., and BarbasC.F.3rd (1994). Human antibodies from combinatorial libraries.Advances in Immunology57, 191–280.
28.
de KruifJ., van der Vuurst de VriesA-R., CilentiL., BoelE., van EwijkW., and LogtenbergT. (1996). New perspectives on recombinant human antibodies.Immunology Today17, 453–455.
29.
DevlinJ.J., PanganibanL.C., and DevlinP.E. (1990). Random peptide libraries: a source of specific protein binding molecules.Science249, 404–406.
30.
Anon. (1986). Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes.Official Journal of the European CommunitiesL358, 1–29.
31.
Anon. (1986). European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, 51 pp. Strasbourg: Council of Europe.
Anon. (1992). Report of the Animal Procedures Committee for 1991, Appendix II, Cmnd 2048, 37 pp. London: HMSO.
34.
Anon. (1995). Tierschutzbericht 1995, Drucksache 13/350, pp. 59–60. Bonn: Bundesministerium für Ernährung, Landwirtschaft und Forsten.
35.
Anon. (1994). The [Swedish] Animal Protection Act (1988:535, as amended by 1990:628, 1991:1688 and 1992:1095). In Provisions and General Recommendations Relating to the Use of Animals for Scientific Purposes (ed. LundgrenO.), pp. 1–5. Stockholm: Karl Olov Öster.
36.
Anon. (1994). General recommendations of the National Board for Laboratory Animals on the treatment of certain matters relating to ethical reviews of the use of animals for scientific purposes (LSFS/Statute book of the National Board of Agriculture/1990:21, Subject no L29). In Provisions and General Recommendations Relating to the Use of Animals for Scientific Purposes (ed LundgrenO.), pp. 43–45. Stockholm: Karl Olov Öster.